MTIC - PET/CT Centre
Low Radiation Dose
Quick turnaround
A world-class fusion of nuclear medicine, scientific and technical expertise delivering patient-centred precision medicine through clinical PET/CT services, research and development in the emerging field of theranostics.
Specialising in molecular imaging and radionuclide therapy, providing accessible services to our community
At MTIC, patient care is our top priority. We strive to make our services easily accessible to all of our patients.
Our ServicesBringing State-of-the-Art
Imaging to Our Patients
We are dedicated to providing the latest and greatest in medical imaging technology to our patients.
Partnerships
MTIC provides patient-centered care with the help of PreMIT and our international partners, who offer early access to emerging technologies and clinical trial enrollment, and support from identification of treatment targets to diagnostic and therapeutic radiopharmaceutical manufacture, distribution and clinical application.
Diagnosis & Treatment
We've partnered with Siemens Healthineers, this will allow us to provide the latest in medical imaging technology using the Siemens Quadra PET/CT scanner and a theranostic facility for our patients to participate in new and innovative clinical trials.
MTIC Team
With 30+ years of experience in nuclear medicine, PET imaging and theranostics, Professor Rod Hicks has assembled a team of experts with a track-record of innovation in healthcare delivery, to improve diagnosis and treatment planning and ultimately deliver better patient outcomes.
PreMIT
PreMIT, under guidance of its Scientific Advisory Board, integrates latest developments in genomics, imaging, and therapies to advance theranostic paradigm and offer collaboration opportunities for researchers and companies.
Professor Rodney Hicks
Founder, Chief Medical Officer, and Board Chair of Precision Molecular Imaging and Theranostics (PreMIT Pty Ltd.)
As a key opinion leader in nuclear medicine and oncology globally, Rod has unparalleled credentials to lead development of novel theranostic paradigms and to coordinate research that seeks to develop molecular imaging probes from target to market.
Professor Hicks has been an innovator in positron emission tomography (PET) and therapeutic use of radiopharmaceuticals for over 30 years. By pioneering multi-tracer PET for profiling of tumour heterogeneity, his innovative thinking and practical application of molecular imaging and theranostic solutions has enabled his academic and industry collaborators to translate personalised medicine from a lofty ideal to reality for many people with cancer.
Leading the Way in
Advanced Medical Imaging
Melbourne Theranostic Innovation Centre has partnered with Siemens Healthineers to provide patients with access to the world's most advanced and sensitive whole-body PET/CT scanner, the Siemens Biograph Vision Quadra, that allows faster, more accurate and lower dose scans with lower radiation risk, especially beneficial for cancer screening, follow-up, children, and pregnant women.
Read MoreDiscover the Benefits of Advanced Medical Imaging
Unlock the full potential of medical imaging with the latest technology.
Blog Posts
.jpg)
Professor Hicks featured
